Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Title: Amorphous Solid dispersions. What’s next?
Speaker: Márcio Temtem
Date: Tuesday, March 13th, 2018
- Review of the market portfolio
- Saving API during Formulation Screening (intermediate and drug product)
- Addressing scale up challenges
- Alternative manufacturing process